Table of Contents

1. Methodology and Scope

1.1. Market Segmentation & Scope
1.1.1. Technology
1.1.2. Product
1.1.3. Application
1.1.4. Workflow
1.1.5. End-use
1.1.6. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives

2. Executive Summary

2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Insights

3. Japan Next Generation Sequencing Market Variables, Trends & Scope

3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Growth in the Adoption of Genome-Focused Pharmacology Propels the Growth of the Market
3.2.1.2. Development of companion diagnostics and personalized medicine
3.2.1.3. Rise in competition among prominent market entities
3.2.1.4. Rising clinical opportunity for NGS technology
3.2.1.5. Technological advancements in cloud computing and data integration
3.2.1.6. Growing healthcare expenditure supporting development of effective diagnostic & therapeutic procedures for cancer.
3.2.1.7. Increasing prevalence of cancer
3.2.2. Market restraint analysis
3.2.2.1. Complexity During Implementation of NGS in the Clinical Lab May Impede the Growth of the Market
3.2.2.2. Non–value-based NGS reimbursement policy and regulation status
3.2.2.3. Challenges associated with NGS implementation.
3.3. Japan Next Generation Sequencing Market Analysis Tools
3.3.1. SWOT analysis; by factor (political & legal, economic, and technological)
3.3.2. Porter’s Five Forces Analysis
3.3.3. COVID-19 Impact Analysis

4. Japan Next Generation Sequencing Market: Technology Business Analysis

4.1. Next Generation Sequencing Market: Technology Movement Analysis
4.2. Targeted Sequencing & Resequencing
4.2.1. Targeted Sequencing & Resequencing Market Estimates And Forecast, 2025 - 2033 (USD Million)
4.2.1.1. DNA-based targeted sequencing & resequencing
4.2.1.1.1. DNA-based targeted sequencing & resequencing market estimates and forecast, 2025 - 2033 (USD Million)
4.2.1.2. RNA-based targeted sequencing & resequencing
4.2.1.2.1. RNA-based targeted sequencing & resequencing market estimates and forecast, 2025 - 2033 (USD Million)
4.3. Whole Genome Sequencing
4.3.1. Whole Genome Sequencing Market Estimates And Forecast, 2025 - 2033 (USD Million)
4.4. Whole Exome Sequencing
4.4.1. Whole Exome Sequencing Market Estimates And Forecast, 2025 - 2033 (USD Million)

5. Japan Next Generation Sequencing Market: Product Business Analysis

5.1. Next Generation Sequencing Market: Product Movement Analysis
5.2. Platforms
5.2.1. Platforms Market Estimates And Forecast, 2025 - 2033 (USD Million)
5.2.1.1. Sequencing
5.2.1.1.1. Sequencing platforms market estimates and forecast, 2025 - 2033 (USD Million)
5.2.1.2. Data Analysis
5.2.1.2.1. Data analysis platforms market estimates and forecast, 2025 - 2033 (USD Million
5.3. Consumables
5.3.1. Consumables market estimates and forecast, 2025 - 2033 (USD million)
5.3.2. Sample Preparation
5.3.2.1. Sample preparation market estimates and forecast, 2025 - 2033 (USD Million)
5.3.3. Target Enrichment
5.3.3.1. Target enrichment market estimates and forecast, 2025 - 2033 (USD Million)
5.3.4. Others
5.3.4.1. Others market estimates and forecast, 2025 - 2033 (USD Million)

6. Japan Next Generation Sequencing Market: Application Business Analysis

6.1. Next Generation Sequencing Market: Application Movement Analysis
6.2. Oncology
6.2.1. Oncology Market Estimates And Forecast, 2025 - 2033 (USD Million)
6.2.2. Diagnostics & Screening
6.2.2.1. Diagnostics & screening market estimates and forecast, 2025 - 2033 (USD Million)
6.2.2.2. Oncology screening
6.2.2.2.1. Oncology screening market estimates and forecast, 2025 - 2033 (USD Million)
6.2.2.2.2. Sporadic cancer screening market estimates and forecast, 2025 - 2033 (USD Million)
6.2.2.2.3. Inherited cancer screening market estimates and forecast, 2025 - 2033 (USD Million)
6.2.2.3. Companion diagnostics
6.2.2.3.1. Companion diagnostics market estimates and forecast, 2025 - 2033 (USD Million)
6.2.2.4. Other diagnostics
6.2.2.4.1. Other diagnostics market estimates and forecast, 2025 - 2033 (USD Million)
6.2.3. Research Studies
6.2.3.1. Research studies market estimates and forecast, 2025 - 2033 (USD Million)
6.3. Clinical investigation
6.3.1. Clinical investigation market estimates and forecast, 2025 - 2033 (USD Million)
6.3.2. Infectious Diseases
6.3.2.1. Infectious diseases market estimates and forecast, 2025 - 2033 (USD Million)
6.3.3. Idiopathic Diseases
6.3.3.1. Idiopathic diseases market estimates and forecast, 2025 - 2033 (USD Million)
6.3.4. Inherited Diseases
6.3.4.1. Inherited diseases market estimates and forecast, 2025 - 2033 (USD Million)
6.3.5. Non-Communicable/Other Diseases
6.3.5.1. Non-communicable/other diseases market estimates and forecast, 2025 - 2033 (USD Million)
6.4. Reproductive Health
6.4.1. Reproductive Health Market Estimates And Forecast, 2025 - 2033 (USD Million)
6.4.2. NIPT
6.4.2.1. NIPT market estimates and forecast, 2025 - 2033 (USD Million)
6.4.2.2. Aneuploidy
6.4.2.2.1. Aneuploidy market estimates and forecast, 2025 - 2033 (USD Million)
6.4.2.3. Microdeletions
6.4.2.3.1. Microdeletions market estimates and forecast, 2025 - 2033 (USD Million)
6.4.3. PGT
6.4.3.1. PGT market estimates and forecast, 2025 - 2033 (USD Million)
6.4.4. Newborn Genetic Screening
6.4.4.1. Newborn genetic screening market estimates and forecast, 2025 - 2033 (USD Million)
6.4.5. Single Gene Analysis
6.4.5.1. Single gene analysis market estimates and forecast, 2025 - 2033 (USD Million)
6.5. HLA Typing/Immune System Monitoring
6.5.1. HLA Typing/Immune System Monitoring Market Estimates And Forecast, 2025 - 2033 (USD Million)
6.6. Metagenomics, Epidemiology & Drug Development
6.6.1. Metagenomics, Epidemiology & Drug Development Market Estimates And Forecast, 2025 - 2033 (USD Million)
6.7. Agrigenomics & Forensics
6.7.1. Agrigenomics & Forensics Market Estimates And Forecast, 2025 - 2033 (USD Million)
6.8. Consumer Genomics
6.8.1. Consumer Genomics Market Estimates And Forecast, 2025 - 2033 (USD Million)

7. Japan Next Generation Sequencing Market: Workflow Business Analysis

7.1. Next Generation Sequencing Market: Workflow Movement Analysis
7.2. Presequencing
7.2.1. Pre-Sequencing Market Estimates And Forecast, 2025 - 2033 (USD Million)
7.2.1.1. NGS library preparation kits
7.2.1.1.1. NGS library preparation kits market estimates and forecast, 2025 - 2033 (USD Million)
7.2.1.2. Semiautomated library preparation
7.2.1.2.1. Semiautomated library preparation market estimates and forecast, 2025 - 2033 (USD Million)
7.2.1.3. Automated library preparation
7.2.1.3.1. Automated library preparation market estimates and forecast, 2025 - 2033 (USD Million)
7.3. Sequencing
7.3.1. Sequencing Market Estimates And Forecast, 2025 - 2033 (USD Million)
7.4. Data Analysis
7.4.1. Data Analysis Market Estimates And Forecast, 2025 - 2033 (USD Million)
7.4.2. Primary Data Ngs Analysis
7.4.2.1. Primary data analysis market estimates and forecast, 2025 - 2033 (USD Million)
7.4.3. Secondary Data Analysis
7.4.3.1. Secondary data analysis market estimates and forecast, 2025 - 2033 (USD Million)
7.4.4. Tertiary Data Analysis
7.4.4.1. Tertiary data analysis market estimates and forecast, 2025 - 2033 (USD Million)

8. Japan Next Generation Sequencing Market: End-use Business Analysis

8.1. Next Generation Sequencing Market: End-use Movement Analysis
8.2. Academic Research
8.2.1. Academic Research Market Estimates And Forecast, 2025 - 2033 (USD Million)
8.3. Clinical Research
8.3.1. Clinical Research Market Estimates And Forecast, 2025 - 2033 (USD Million)
8.4. Hospitals & Clinics
8.4.1. Hospitals & Clinics Market Estimates And Forecast, 2025 - 2033 (USD Million)
8.5. Pharmaceutical & Biotech Entities
8.5.1. Pharmaceutical & Biotech Entities Market Estimates And Forecast, 2025 - 2033 (USD Million)
8.6. Other Users
8.6.1. Other Users Market Estimates And Forecast, 2025 - 2033 (USD Million)

9. Competitive Landscape

9.1. Recent Developments & Impact Analysis, By Key Market Participants
9.2. Company/Competition Categorization
9.3. Key company market share analysis, 2023
9.4. Participants Overview
9.4.1. Illumina, Inc
9.4.1.1. Company overview
9.4.1.2. Financial performance
9.4.1.3. Product benchmarking
9.4.1.4. Strategic initiatives
9.4.2. QIAGEN
9.4.2.1. Company overview
9.4.2.2. Financial performance
9.4.2.3. Product benchmarking
9.4.2.4. Strategic initiatives
9.4.3. Thermo Fisher Scientific, Inc
9.4.3.1. Company overview
9.4.3.2. Financial performance
9.4.3.3. Product benchmarking
9.4.3.4. Strategic initiatives
9.4.4. BGI
9.4.4.1. Company overview
9.4.4.2. Financial performance
9.4.4.3. Product benchmarking
9.4.4.4. Strategic initiatives
9.4.5. Pacific Biosciences
9.4.5.1. Company overview
9.4.5.2. Financial performance
9.4.5.3. Product benchmarking
9.4.5.4. Strategic initiatives
9.4.6. Bio Rad Laboratories
9.4.6.1. Company overview
9.4.6.2. Financial performance
9.4.6.3. Product benchmarking
9.4.6.4. Strategic initiatives
9.4.7. Oxford Nanopore Technologies, Inc
9.4.7.1. Company overview
9.4.7.2. Financial performance
9.4.7.3. Product benchmarking
9.4.7.4. Strategic initiatives
9.4.8. Myriad Genetics. Inc.
9.4.8.1. Company overview
9.4.8.2. Financial performance
9.4.8.3. Product benchmarking
9.4.8.4. Strategic initiatives
9.4.9. Agilent Technologies, Inc.
9.4.9.1. Company overview
9.4.9.2. Financial performance
9.4.9.3. Product benchmarking
9.4.9.4. Strategic initiatives
9.4.10. Eurofins Scientific
9.4.10.1. Company overview
9.4.10.2. Financial performance
9.4.10.3. Product benchmarking
9.4.10.4. Strategic initiatives